Skip to main content
Jesica (Christensen) Herrick, MD, Infectious Disease, Chicago, IL

Jesica Allyn (Christensen) Herrick MD


Physician

Join to View Full Profile
  • 808 S Wood StMSC 735Chicago, IL 60612

  • Phone+1 312-996-3418

  • Fax+1 312-413-1421

Are you Dr. Herrick?

Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.

  • Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Summary

  • Dr. Jesica (Christensen) Herrick, MD is an infectious disease specialist in Chicago, Illinois. She is currently licensed to practice medicine in Illinois.

Education & Training

  • National Institutes of Health Clinical Center
    National Institutes of Health Clinical CenterFellowship, Infectious Disease, 2009 - 2011
  • University of Illinois College of Medicine at Chicago
    University of Illinois College of Medicine at ChicagoResidency, Internal Medicine, 2005 - 2008
  • University of Nebraska College of Medicine
    University of Nebraska College of MedicineClass of 2005

Certifications & Licensure

  • IL State Medical License
    IL State Medical License 2005 - 2026
  • IL State Medical License
    IL State Medical License 2008 - 2026
  • Internal Medicine
    American Board of Internal Medicine Internal Medicine
  • Infectious Disease
    American Board of Internal Medicine Infectious Disease

Publications & Presentations

PubMed

Press Mentions

  • Kids’ Vaccines Are ‘A Game Changer,’ Experts Say—Here’s What Else Needs to Happen to End the Covid Pandemic
    Kids’ Vaccines Are ‘A Game Changer,’ Experts Say—Here’s What Else Needs to Happen to End the Covid PandemicJune 28th, 2022
  • How Covid Vaccines for Teenagers Underneath 5 Might Help Finish the Pandemic: Consultants
    How Covid Vaccines for Teenagers Underneath 5 Might Help Finish the Pandemic: ConsultantsJune 28th, 2022
  • UIC Opens Phase 3 Monoclonal Antibody Clinical Trial
    UIC Opens Phase 3 Monoclonal Antibody Clinical TrialOctober 29th, 2020